Cure & Care Drugs Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 13-12-2024
- Paid Up Capital ₹ 0.10 M
as on 13-12-2024
- Company Age 5 Year, 12 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.00 M
as on 13-12-2024
- Revenue 2665.08%
(FY 2023)
- Ebitda 349.43%
(FY 2023)
- Net Worth 11.60%
(FY 2023)
- Total Assets 201.59%
(FY 2023)
About Cure & Care Drugs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.00 M.
Rajesh Singh, Ravish Tyagi, and Sindhu Vats serve as directors at the Company.
- CIN/LLPIN
U24304UR2020PTC010620
- Company No.
010620
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jan 2020
- Date of AGM
29 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Haridwar, Uttarakhand, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Cure & Care Drugs?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Singh  | Director | 25-Apr-2022 | Current |
| Ravish Tyagi | Director | 06-Jan-2020 | Current |
| Sindhu Vats | Director | 14-Nov-2022 | Current |
Financial Performance of Cure & Care Drugs.
Cure & Care Drugs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 2665.08% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 11.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cure & Care Drugs?
Unlock access to Cure & Care Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Cure & Care Pesticide Private LimitedActive 1 year 8 months
Ravish Tyagi and Sindhu Vats are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 10 Dec 2021 | ₹5.00 M | Open |
How Many Employees Work at Cure & Care Drugs?
Cure & Care Drugs has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cure & Care Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cure & Care Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
